Alnylam Pharmaceuticals | ALNY - Acción

Precio De Mercado
301.20
Cambio Diario
-0.91 -0.30%
Mensual
-4.71%
Anual
14.42%
Q2 Expectativa
299.00




Acción Cambio Fecha
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Takeda JPY 1.41T 107.71B 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12